Amarin Corp Plc (AMRN)

[Pyrrhonian]

Well guys, I took a big chunk of time yesterday and crunched lots of numbers from various trials, and combed over the R-IT and ANCHOR data again quite a bit, and here's my Happy Thanksgiving to you:

I no longer think the result might have been insignificant if placebo group were given a truly inert placebo, but I do think the 25% RRR of MACE is overblown by more than the "5% at most" (meaning, 20% of the 25% RRR) that proponents of R-IT and AMRN are touting. The true RRR of MACE in the study is imo likely closer to 13%-16%, but probably not less than that, according to my research.

Cheers

(caveat--still not at all sure how FDA will handle the issue)